Regulatory Requirements for Global Clinical Trials (GCTs) in India under CDSCO
GCTs are trials conducted concurrently in multiple countries following a common protocol. In India, these trials are typically part of larger drug development programs seeking global marketing authorization. Due to the complex regulatory environment and ethical sensitivities, GCTs require stringent oversight by local authorities, including the CDSCO and Drug Controller General of India (DCGI).
Click to read the full article.